Conduit Pharmaceuticals Inc. (CDT) — Strategic Asset Allocation Index
Conduit Pharmaceuticals Inc. (CDT) has a Strategic Asset Allocation Index of 8.9% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $122.85 Million) total $122.85 Million, measured against net assets of $1.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check CDT tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Conduit Pharmaceuticals Inc. (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Conduit Pharmaceuticals Inc. from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CDT stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|